[Ip-health] EU Commission issues 2 consultations on pharmaceuticals

[Michelle Childs]

--
[ Picked text/plain from multipart/alternative ]
E-DRUG: EU Commission issues 2 consultations on pharmaceuticals
---------------------------------------------------------------
[Crossposted with thanks from the HAI Network; WB]

Better regulation of pharmaceuticals: towards a simpler, clearer and
more
flexible framework on variations: Public Consultation (co-decision part)

<http://ec.europa.eu/enterprise/pharmaceuticals/varreg/index.htm>

---

Commission launches a Public Consultation on the co-decision part of the
revision of the Variations Regulations. The consultation paper, together
with detailed explanations on the consultation process, is available
here:

http://ec.europa.eu/enterprise/pharmaceuticals/varreg/
variations_consultation_paper_codecision_20070710.pdf

----

Commission launches a public consultation on the future of
pharmaceuticals
for human use in Europe The pharmaceutical sector has been and
remains a key strategic sector in Europe. The future of this sector
is a crucial matter for the EU. Today, the Commission launches a
broad public debate on the future of pharmaceuticals for human use in
the Community. All stakeholders dealing with medicines for human use
are invited to participate. The Consultation Paper which forms the
basis for the public consultation is available here:

http://ec.europa.eu/enterprise/pharmaceuticals/pharmacos/docs/
doc2007/2007_07/consultationpaper-2007-07-19.pdf

Following this consultation, the Commission intends to address a
Communication to the Council of the European Union and to the European
Parliament on the future of the EU single market in pharmaceuticals for
human use, outlining its vision and strategy for the sector, as well as
concrete action items. The Communication will build on this public
consultation and will outline how its outcome was taken into account.


Michelle Childs
Head of European Affairs
Knowledge Ecology International
michelle.childs@cptech.org